share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Garg Vipin K

SEC announcement ·  Feb 6 07:04
Summary by Futu AI
Vipin K Garg, President and CEO of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1st and 2nd, 2024. Garg acquired a total of 35,495 shares of Altimmune common stock through the exercise of derivative securities at no cost. Concurrently, he disposed of 15,689 shares at prices ranging from $9.32 to $9.88 per share, resulting in a total market value of $150,316.76. Following these transactions, Garg's direct holdings in Altimmune amounted to 292,028 shares of common stock.
Vipin K Garg, President and CEO of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1st and 2nd, 2024. Garg acquired a total of 35,495 shares of Altimmune common stock through the exercise of derivative securities at no cost. Concurrently, he disposed of 15,689 shares at prices ranging from $9.32 to $9.88 per share, resulting in a total market value of $150,316.76. Following these transactions, Garg's direct holdings in Altimmune amounted to 292,028 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.